The Top 10 DividendRank'ed Nasdaq 100 Components
By The Online Investor Staff, updated Thu., Apr. 18, 6:28 AM
| This Slide: #2 of 10 |
#9. AstraZeneca Plc (NASDAQ:AZN) — 2.9% YIELD
AstraZeneca is a holding company. Through its subsidiaries, Co. is engaged in pharmaceutical business focusing on the research, development, manufacturing and commercialization of prescription medicines. Co. is focused on its therapy areas: Oncology, which provides Tagrisso (osimertinib) for lung cancer; BioPharmaceuticals, which provides Farxiga/ Forxiga (dapagliflozin) for Type-2 diabetes, heart failure with reduced ejection fraction and chronic kidney disease; and Rare Disease, which provides Soliris (eculizumab) for paroxysmal nocturnal haemoglobinuria, atypical haemolytic uraemic syndrome, generalised myasthenia gravis and neuromyelitis optica spectrum disorder.
|
|||||||||||||||||||||
Open the AZN Page at The Online Investor (in a new window) »
 Free AZN Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Buy (3.41 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: AZN Stock Forecast Based on Zacks ABR data; powered by Xignite |
